José de León
About
José de León is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology.
According to data from OpenAlex, José de León has authored 414 papers receiving a total of 14.9k indexed citations (citations by other indexed papers that have themselves been cited), including 240 papers in Psychiatry and Mental health, 62 papers in Clinical Psychology and 60 papers in Pharmacology. Recurrent topics in José de León's work include Schizophrenia research and treatment (175 papers), Bipolar Disorder and Treatment (71 papers) and Pharmacogenetics and Drug Metabolism (60 papers). José de León is often cited by papers focused on Schizophrenia research and treatment (175 papers), Bipolar Disorder and Treatment (71 papers) and Pharmacogenetics and Drug Metabolism (60 papers). José de León collaborates with scholars based in United States, Spain and China. José de León's co-authors include Francisco J. Díaz, Edoardo Spina, Margaret T. Susce, Manuel J. Cuesta, Víctor Peralta, Enrique Baca‐García, George M. Simpson, María J. Arranz, Pilar A. Sáiz and Richard C. Josiassen and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and American Journal of Psychiatry.
In The Last Decade
José de León
401 papers receiving 14.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| José de León United States | 64 | 7.8k | 2.8k | 2.4k | 2.2k | 1.8k | 414 | 14.9k | ||
| T. Scott Stroup United States | 63 | 13.6k 1.7× | 3.5k 1.3× | 1.9k 0.8× | 369 0.2× | 1.3k 0.7× | 185 | 18.8k | ||
| Werner Kissling Germany | 55 | 9.8k 1.3× | 3.4k 1.2× | 730 0.3× | 462 0.2× | 745 0.4× | 205 | 14.1k | ||
| Joseph P. McEvoy United States | 71 | 15.5k 2.0× | 4.1k 1.5× | 2.2k 0.9× | 350 0.2× | 1.7k 0.9× | 227 | 20.6k | ||
| Christoph Hiemke Germany | 52 | 3.8k 0.5× | 565 0.2× | 1.3k 0.5× | 1.4k 0.6× | 1.7k 0.9× | 406 | 11.5k | ||
| Leslie Citrome United States | 58 | 8.9k 1.1× | 2.9k 1.1× | 939 0.4× | 319 0.1× | 874 0.5× | 435 | 13.3k | ||
| Stefan Leucht Germany | 96 | 22.2k 2.8× | 6.7k 2.4× | 2.3k 1.0× | 975 0.5× | 2.1k 1.2× | 485 | 34.9k | ||
| Richard I. Shader United States | 81 | 5.5k 0.7× | 1.4k 0.5× | 1.4k 0.6× | 5.2k 2.4× | 1.9k 1.0× | 549 | 21.5k | ||
| Corrado Barbui Italy | 63 | 7.7k 1.0× | 5.8k 2.1× | 912 0.4× | 340 0.2× | 771 0.4× | 473 | 20.4k | ||
| Stephen M. Stahl United States | 66 | 6.6k 0.8× | 2.3k 0.8× | 1.4k 0.6× | 375 0.2× | 2.6k 1.4× | 425 | 16.7k | ||
| Stephen R. Marder United States | 74 | 14.2k 1.8× | 4.0k 1.4× | 1.1k 0.5× | 302 0.1× | 1.7k 0.9× | 319 | 20.5k |
Countries citing papers authored by José de León
Since
Specialization
Citations
This map shows the geographic impact of José de León's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José de León with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José de León more than expected).
Fields of papers citing papers by José de León
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by José de León. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José de León. The network helps show where José de León may publish in the future.
Co-authorship network of co-authors of José de León
This figure shows the co-authorship network connecting the top 25 collaborators of José de León. A scholar is included among the top collaborators of José de León based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José de León. José de León is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Cuevas, Carlos De las, Emílio J. Sanz, & José de León. (2025). Clozapine-treated patients and myocardial infarction in adults: a pharmacovigilance study in VigiBase interpreted in the context of the literature. Expert Opinion on Drug Safety. 1–11.
2.
Cuevas, Carlos De las, Emílio J. Sanz, & José de León. (2025). Fatal Outcomes in Use of Clozapine. Journal of Clinical Psychopharmacology. 45(6). 547–553.
3.
Díaz, Francisco J., María Luisa Barrigón, Ismaël Conejero, et al.. (2024). Correlation between low sleep satisfaction and death wish in a three-month Ecological Momentary Assessment study. PubMed. 18(1). 60–64.
4.
León, José de, Can‐Jun Ruan, Georgios Schoretsanitis, et al.. (2024). Investigating in VigiBase over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: focus on high lethality and the association with aspiration pneumonia. Expert Opinion on Drug Metabolism & Toxicology. 20(8). 857–871.
5.
Cuevas, Carlos De las, Emílio J. Sanz, & José de León. (2024). Pharmacovigilance in Action: Utilizing VigiBase Data to Improve Clozapine Safety. Patient Preference and Adherence. Volume 18. 2261–2280.
6.
Ruan, Can‐Jun, et al.. (2023). A Chinese medicine called Danggui Longhui may be a new clinically relevant clozapine inducer: Two case reports identified by therapeutic drug monitoring. Schizophrenia Research. 268. 308–311.
7.
Cuevas, Carlos De las, Emílio J. Sanz, Christoph U. Correll, et al.. (2023). Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK. Schizophrenia Research. 268. 175–188.
8.
Cuevas, Carlos De las, Emílio J. Sanz, & José de León. (2023). Adverse drug reactions and their fatal outcomes in clozapine patients in VigiBase: Comparing the top four reporting countries (US, UK, Canada and Australia). Schizophrenia Research. 268. 165–174.
9.
León, José de & Carlos De las Cuevas. (2023). Will ChatGPT3 Substitute for us as Clozapine Experts?. Journal of Clinical Psychopharmacology. 43(5). 400–402.
10.
Filippis, Renato de, Carlos De las Cuevas, Emílio J. Sanz, et al.. (2023). Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database. Schizophrenia Research. 268. 118–130.
11.
Ertuğrul, Aygün, et al.. (2022). Valproate, obesity and other causes of clozapine poor metabolism in the context of rapid titration may explain clozapine-induced myocarditis: A re-analysis of a Turkish case series. Revista de Psiquiatría y Salud Mental (English Edition). 15(4). 281–286.
12.
Cuevas, Carlos De las, Emílio J. Sanz, Can‐Jun Ruan, & José de León. (2021). Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: Focus on reports from various countries. Revista de Psiquiatría y Salud Mental. 15(4). 238–250.
13.
Lazáry, Judit, et al.. (2021). Adherence to psychiatric medications: Comparing patients with schizophrenia, bipolar disorder and major depression.. PubMed. 23(4). 363–373.
14.
Cuevas, Carlos De las, et al.. (2021). Effect of necessity‐concern framework and polypharmacy on treatment adherence in psychiatric patients. Comparing an Argentinian with a Spanish sample. Human Psychopharmacology Clinical and Experimental. 36(4). e2776–e2776.
15.
Cuevas, Carlos De las & José de León. (2020). <p>Self-Report for Measuring and Predicting Medication Adherence: Experts’ Experience in Predicting Adherence in Stable Psychiatric Outpatients and in Pharmacokinetics</p>. Patient Preference and Adherence. Volume 14. 1823–1842.
16.
Cuevas, Carlos De las, Moisés Betancort, & José de León. (2020). The necessity‐concern framework in the assessment of treatment adherence of psychiatric patients and the role of polypharmacy in a Spanish sample. Human Psychopharmacology Clinical and Experimental. 35(1). e2721–e2721.
17.
Schoretsanitis, Georgios, John M. Kane, & José de León. (2020). Adding Oral Contraceptives to Clozapine May Require Halving the Clozapine Dose. Journal of Clinical Psychopharmacology. 40(3). 308–310.
18.
Rohde, Christopher, Dan Siskind, José de León, & Jimmi Nielsen. (2019). Antipsychotic medication exposure, clozapine, and pneumonia: results from a self‐controlled study. Acta Psychiatrica Scandinavica. 142(2). 78–86.
19.
Cuevas, Carlos De las, et al.. (2019). Ethnopsychopharmacology study of patients' beliefs regarding concerns about and necessity of taking psychiatric medications. Human Psychopharmacology Clinical and Experimental. 34(2). e2688–e2688.
20.
Brenzel, Allen, et al.. (2016). Two Sudden and Unexpected Deaths of Patients with Schizophrenia Associated with Intramuscular Injections of Antipsychotics and Practice Guidelines to Limit the Use of High Doses of Intramuscular Antipsychotics. Case Reports in Psychiatry. 2016. 1–14.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by T. Scott Stroup Breakdown of academic impact, for papers by Werner Kissling Breakdown of academic impact, for papers by Joseph P. McEvoy Breakdown of academic impact, for papers by Christoph Hiemke Breakdown of academic impact, for papers by Leslie Citrome Breakdown of academic impact, for papers by Stefan Leucht Breakdown of academic impact, for papers by Richard I. Shader Breakdown of academic impact, for papers by Corrado Barbui Breakdown of academic impact, for papers by Stephen M. Stahl Breakdown of academic impact, for papers by Stephen R. Marder